Compare CSBR & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | MCHX |
|---|---|---|
| Founded | 1985 | 2003 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0M | 76.4M |
| IPO Year | N/A | N/A |
| Metric | CSBR | MCHX |
|---|---|---|
| Price | $6.03 | $1.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 6.2K | ★ 24.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | $6.70 |
| P/E Ratio | $33.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.59 | $1.26 |
| 52 Week High | $11.16 | $2.31 |
| Indicator | CSBR | MCHX |
|---|---|---|
| Relative Strength Index (RSI) | 36.31 | 34.24 |
| Support Level | $6.53 | $1.59 |
| Resistance Level | $6.34 | $1.62 |
| Average True Range (ATR) | 0.39 | 0.07 |
| MACD | -0.13 | -0.01 |
| Stochastic Oscillator | 6.07 | 10.00 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.